ClinicalTrialsFinder

EGFR Gene Mutation Clinical Trials in Amsterdam, North Holland

1 recruitingAmsterdam, North Holland, Netherlands

Showing 1–1 of 1 trials

Recruiting
Phase 2

Whole Body HER3 Quantification With Radiolabelled Patritumab Deruxtecan (HER3-DXd) PET/CT

Non-Small-Cell Lung CarcinomaEGFR Gene MutationAdvanced Non-Small Cell Squamous Lung Cancer
The Netherlands Cancer Institute16 enrolled1 locationNCT06222489